Articles Posted in Xarelto

by

Xarelto is a member of a new class of oral anticoagulant medications proscribed to patients who suffer from a serious medical condition known as atrial fibrillation (Afib). Afib patients are at increased risk for certain types of serious medical conditions related to clotting disorders. When an Afib patient in not properly medicated, he or she is more likely to develop large and dangerous blood clots deep within his or her veins.

perscription-drug-case-1156714-mThese clots can develop deep within the legs and break loose, causing a medical condition known as deep vein thrombosis (DVT). A DVT clot can then travel through the body’s circulatory system until it reaches a vital organ. The clot can puncture the lung, causing a pulmonary embolism (PE), which is often fatal to victims. Additionally, the clots can block the blood supply to the brain, causing the brain to be deprived of oxygen-rich blood and resulting in a stroke. Continue reading

by

Pradaxa, Xarelto, and Eliquis are all members of a relatively new class of drugs known as new oral anticoagulants (NOACs). These drugs were designed for patients who suffer from a medical condition known as atrial fibrillation (Afib). Afib patients need a blood thinning medication to prevent deep vein clots from forming.

pillsA deep vein clot can form a serous medical condition known as Deep Vein Thrombosis (DVT), where the clot forms in the veins of the legs and then breaks loose and travels though the blood system, where it can do serious damage. If the clot blocks the flow of blood to the brain, the patient will suffer a stroke, which can result in permanent injury or death. If the clot enters the lungs, it can puncture the pleural membrane, causing a serious internal bleeding condition known as a pulmonary embolism (PE). Continue reading

by

The general public is becoming more aware of the dangers of Xarelto. The problem with Xarelto is it has been shown to cause serious internal bleeding disorders, clotting disorders and other serious heath problems. There is currently an antidote for the irreversible symptoms of Xarelto bleeding disorders, but it is still in the experimental stages, and the company needs to undergo additional testing before the United States Food and Drug Administration (FDA) will approve the drug for general use. The antidote is an injectable medication being developed by another drug company, and it will be available for use in the emergency room if and when it is approved.

medication pills.jpgTo help keep sales up with dangers being made known to atrial fibrillation (Afib) patients, Bayer is hoping to find additional customers for their new drug. According to a recent news feature from RTT News, Bayer is now conducting clinical investigations into using Xarelto to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) in cancer patients, in addition to the Afib patients for which is currently approved.
Continue reading

by

Xarelto is an anticoagulant medication manufactured by Bayer AG, the German pharmaceutical giant, and Janssen, a subsidiary of Johnson & Johnson, markets it in the United States.

courtroom-1-1207444-m.jpgXarelto is one of three relatively new forms of medication marketed to treat patients who suffer from a condition known as atrial fibrillation (Afib). The other drugs in this class of New Oral Anticoagulants (NOACs) include Pradaxa and Eliquis. All three of these medications are essentially designed to be replacements for Warfarin (Coumadin), which has been the longstanding preferred course of treatment for Afib patients to prevent clotting disorders such as stroke and pulmonary embolism (PE).
Continue reading

by

While Bayer AG, the German pharmaceutical giant, has seen a recent increase in quarter-over-quarter profits, sales numbers for their bestselling drug, Xarelto, have actually dropped this past quarter for the first time since the United States Food and Drug Administration (FDA) approved it for market.

money-trading-1-1415239-m.jpgXarelto is a member of a class of drugs known as New Oral Anticogulants (NOACs) and, despite what drug makers claim, has been marketed as a replacement for Warfarin (Coumadin) for patients suffering from a serious medical condition known as atrial fibrillation (Afib). Afib is a serious heart condition, which can cause a patient to have a stroke or other serious clotting disorder. Due to Afib, patients must take either a blood thinner or other anticoagulant to prevent clots from forming. Not only can these clots block an artery causing heart failure or stroke, they can break free from the deep veins in which they formed and travel through the patient’s circulatory system to the lungs. If they puncture a hole in a patient’s lung, it leads to a serious medical condition known as a pulmonary embolism, which often results in death of a patient.
Continue reading

by

Xarelto, like Eliquis and Pradaxa, are members of a class of drugs known as New Oral Anticoagulants (NOACs). While, technically, they are not a blood thinner like Coumadin (Warfarin), as they are closer to a class of medications known as statins, their respective makers hope they will go head-to-head with Warfarin and eventually replace it as the treatment of first resort for many patients.

pills.jpgWarfarin itself has a rather interesting history, as it was first discovered in relation to a disease that was killing cattle in the 1920s. After being created, it was then marketed as a rodenticide agent, and later used (unsuccessfully) by the United States Army as an experimental suicide agent. Eventually, it became used for its current purpose to treat atrial fibrillation patients.
Continue reading

by

According to a recent news feature from the Madison Record, a woman in Texas is suing Bayer Pharmaceuticals AG, and its United States marketing partner Janssen Pharmaceuticals (Johnson & Johnson) for injuries she alleges was a result of her Xarelto prescription.

woman-in-hospital-1051476-m.jpgXarelto is the brand name for a drug known as rivaroxaban. It is a member of a class of drugs known as New Oral Anticoagulants (NOACs). Patients who suffer from various medical conditions including atrial fibrillation (Afib) require an anti-clotting agent. If blood clots form, they can block the flow of blood, causing strokes and other serious issues. If a clot forms and breaks loose, it can travel to other parts of the body, such as the lungs, where it can cause serious internal bleeding known as a pulmonary embolism or PE. Until the creation and FDA approval of NOACs, including Xarelto, Pradaxa, and Eliquis, the most commonly used medication was Warfarin, which is the generic form of Coumadin.

While Coumadin is effective in treating Afib patients, it does require very frequent blood tests to monitor dosage, and patients must also watch their diets closely, as certain foods can alter the rate at which Coumadin is absorbed. If the dosage is off, the patient can have serious consequences including bleeding disorders.
Continue reading

by

These days it is nearly impossible to watch television without seeing commercials for one of three drugs, which are part of a new group of blood thinning medications known as New Oral Anticoagulants (NOACs). This relatively new class of drugs includes big names like Xarelto, Eliquis, and Pradaxa. Xarelto makers, for example, have hired golf legend Arnold Palmer and actor Kevin Nealon to promote their product.

orangepills.jpgAll three of these medications offer what their respective makers claims is a better alternative to long used blood thinner, Warfarin. Patients who suffer from a medical condition known as atrial fibrillation or “Afib” need to take a blood thinning medication, because they are at higher risk of developing blood clots. When a blood clot forms, it can block an artery, causing stroke and heart disease. It can also break free from a vein and travel to the lungs, where it can puncture the tissue. This is a serious and often deadly condition known as a pulmonary embolism (PM).

Warfarin is generally safe and effective when a doctor can frequently monitor a patient’s dosage. If the dosage is off, serious bleeding disorders can occur. This means a patient will have to undergo frequent blood tests and have scheduled follow up visits with their doctor. A patient must also closely watch his or her diet, because certain foods can change the rate at which Warfarin is absorbed. These new drugs, like Xarelto, are supposed to be as effective as Warfarin without the need to constantly monitor the patient’s dosage.
Continue reading

by

Patients who have a serious health condition known as atrial fibrillation (Afib) are required to take blood-thinning medications to prevent stroke, heart disease, pulmonary embolism (PE) and other serious clotting disorders. Traditionally, this means taking Warfarin. Warfarin is a long existing blood thinning medication now available in generic form.

250621_injection_time_-_syringe_with.jpgWhile Warfarin is known to be effective, it does require frequent monitoring of a patient’s blood, so doctors can make dosage changes when necessary. If the dosage is not monitored constantly, they may suffer serious and potentially fatal adverse reactions. Patients must also closely monitor their diets, because certain foods can affect how Warfarin is absorbed in the body, which in turn can affect dosage rates.
Continue reading

by

Xarelto, like Eliquis and Pradaxa, is a blood thinner known as a New Oral Anticoagulant (NOAC) or Factor Xa Inhibitor. Patients at risk for heart disease or with clotting disorders are often required to take an anticoagulant to prevent stroke and other serious medical conditions.

asprin-7238-m.jpgThe traditional therapy used by millions of Americans is aspirin or Warfarin. While Warfarin is generally effective, patients must have frequent blood tests, so their doctors can closely monitor their dose. They must also watch their diets carefully and avoid foods that can change the rate of Warfarin absorption. If the dose if off even slightly, patients can have serious adverse events (side effects), and this is a problem on which Xarelto makers are trying to capitalize.
Continue reading

Contact Information
Boston Office
1 International Pl Unit 1810
Boston, MA 02110
Phone: (617) 777-7777Fax: (617) 722-9999
Taunton Office
60 Court St
Taunton, MA 02780
Disclaimer – The settlements above are only a sample of cases represented by our office. Each case is different and the amount of a potential resolution of your case will vary considerably depending on a substantial amount of factors. Some case results were worked in conjunction with partnering law firms.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Please do not include any confidential or sensitive information in a contact form, text message, or voicemail. The contact form sends information by non-encrypted email, which is not secure. Submitting a contact form, sending a text message, making a phone call, or leaving a voicemail does not create an attorney-client relationship.

Copyright © 2024, Jeffrey Glassman Injury Lawyers
JUSTIA Law Firm Blog Design